• Navigation
  • Content
  • Footer
  • Global
    • Novartis site directory
  • Navigate Novartis
    • Patients & Caregivers
    • Healthcare Professionals
    • Media
    • Investors
Search
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Our Strategy
      • Our Culture and Values
      • Diversity & Inclusion
      • Our Stories
    • Novartis Portfolio
      • Global Product Portfolio
      • Global Clinical Pipeline
    • Media
      • All Novartis News
      • Media Contacts
      • Novartis Media Library
      • Stay Up-To-Date
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
    • Corporate Responsibility
      • Corporate Responsibility at Novartis
      • Expanding Access to Healthcare
      • Ethics, Risk and Compliance
    • Our Business
      • Novartis Oncology
      • Novartis Pharmaceuticals
      • Alcon
      • Sandoz
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardio-Metabolic
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Navigate Novartis
      • Patients & Caregivers
      • Healthcare Professionals
      • Media
      • Investors
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
  • Our Science
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Global Clinical Pipeline
      • Translational Medicine
      • Novartis Clinical Trials
  • Join Us
    • Your Career
      • Novartis Career Search
      • Careers in Research
    • Working at Novartis
      • Corporate Responsibility
      • Diversity & Inclusion
      • Our Culture and Values
    • Academic Programs
      • Students & Scholars
      • The STEP Program
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
Three lessons I’ve learned as an industry postdoc
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • Whatsapp
    • Pinterest
    • LinkedIn
    • Google +
    • Email
  • Jump to Comments
Stories/From Our Labs

Three lessons I’ve learned as an industry postdoc

An immunologist shares tips from a team-based environment. 

By
Kelan Hlavaty
Sep 15, 2016

Shareline

An immunologist shares tips from a team-based environment.
Tweet Tweetpopo

“What is it like to be a postdoc in industry?” This is the question I was repeatedly asked while attending a recent meeting for postdoctoral researchers. Frequently, the follow-up question was, “Are you still doing basic, mechanistic research?”

So I began to reflect on my current training environment at the Novartis Institutes for BioMedical Research (NIBR). It’s certainly different from academia. My lab in Immuno-Oncology is faster-paced than the one I worked in as a graduate student. Resources are abundant, the culture is interconnected and communicative, and there are meetings—many, many meetings.

Yet I am still doing basic research: the kind of science that allows delving into mechanisms towards an integrated understanding of disease beyond druggable targets and is geared toward publications. And there are benefits to doing this work in a team-based environment.

Here are three tips for all scientists, academic or industry, based on my experience at NIBR.

1. Working collaboratively in teams is crucial to move the science forward. 
This sounds like something we’ve all heard, but collaboratively is the key word. Many researchers feel that they can each do their own piece and the science will magically come together in a coherent product. This is rarely the case, even in academia.

In industry, projects often encompass an overwhelming number of moving parts, so team members must learn to communicate and work together effectively. As a postdoc, I benefit from their willingness to partner and coach their colleagues. I work closely, for example, with the microscopy group to visualize how cells that I’ve engineered to display different receptors interact with cancer cells. This team has helped me better understand the function of my cells, and they also have a great sense of humor (a good indicator of a team that works well together). Each microscope is cleverly named after a Game of Thrones character.

2. Good mentors are key to one’s professional development—and to the health of the scientific community. 
Finding an influential mentor can be advantageous for advice, networking, and discussing big decisions. I’m fortunate to be co-mentored by two talented scientists, and our camaraderie and interaction during the interview process had much to do with my decision to pursue this position.

I’ve also found informal mentors. NIBR offers a plethora of opportunities to connect with colleagues across the organization—through a women’s group, a cross-cultural group, a lunch connection program, etc. Even senior leaders get involved in these. Consider the following: through the lunch connection program, I was recently placed in a small group for a meal with NIBR’s new president, Jay Bradner. Our conversation spanned topics ranging from our research to developing the company’s strategic vision to summer travel plans.

At NIBR, there are opportunities for mentoring and conversation between all levels. In addition to having a positive impact on the personal and professional development of individuals, these relationships and interactions build community, making it easier for people with different perspectives to embrace shared goals and work together. And once again, collaboration is key to advancing science.

3. Rejuvenation and work/life balance are absolutely necessary.  
I took a week off this summer to visit my parents and attend a bridal shower. I have to admit, I felt some anxiety about stepping away, and I suggested working from home part of the time. My mentors emphatically cautioned me against this.

“Vacation is VACATION,” they said. “Time away from work is precious and necessary to recharge.”

I followed their advice and spent the week relaxing with my family. When I returned to NIBR, I felt clear-headed with a renewed focus on my experiments. This attitude allowed me to jump back into science full swing, and since then I’ve generated intriguing data that has sent my project in a number of unexpected and exciting directions.

I’ve noticed that most of my NIBR colleagues respect the need for rejuvenation. In general, they’re also more accepting of the concept of work/life balance. Some scientists, for example, need to leave early on certain days to pick up kids from school, and their colleagues respect this balance.

This isn’t to say that those in industry don’t put in long hours or aren’t as motivated—I myself come in to the lab most weekends. But everyone finds a schedule that is sustainable for them and the science doesn’t suffer.

I’m eager to hear the perspectives of the readers of this blog post. Do any of these reflections resonate with you, whether you are a scientist in the pharmaceutical industry or at a university?

Career opportunities

Find career opportunities in Oncology and Immuno-oncology research at Novartis.

Visit our career search page to learn more.

Main image: Novartis imaging expert Alicia Carlson (left) shares her knowledge with postdoctoral researcher Kelan Hlavaty (right). Photo by PJ Kaszas.

Tags: 
Novartis Institutes for BioMedical Research, Postdoc Program, Reimagine Medicine, Careers, Biomedical Jobs

Kelan Hlavaty

Kelan Hlavaty

is a postdoctoral researcher at NIBR working in Immuno-Oncology on CAR T-cell therapies. When not performing exciting experiments in the lab, she enjoys trying new cooking recipes, spending time outdoors, reading thought-provoking books, and, as a new resident of the Boston area, exploring New England.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • Whatsapp
      • Pinterest
      • LinkedIn
      • Google +
      • Email
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Novartis scientists Edward Oakeley (left) and Mevion Oertli use a plasma screen to present their findings to Novartis researchers.
From Our Labs

Reimagining protein sequencing

Wendy Winckler takes some time away from the lab
From Our Labs

Women in Science: Wendy Winckler

Jean Silveri doing work
From Our Labs

Women in Science: Jean Silveri

You are here

  1. Home ›
  2. Stories ›
  3. From Our Labs

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Join Us

    • Career Search

Subscribe to Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • pinterest
  • instagram
Novartis Site Directory
© 2019 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map

This site is intended for a global audience.